medline.ch Onkologie Urologische Tumoren

	[WOLVERINE, aÂ meta-analysis on stereotactic radiotherapy of oligometastases in prostate cancer]. Strahlenther Onkol Dunst J. PMID: 41912926 [PubMed - as supplied by publisher]
	Tislelizumab combined with gemcitabine plus cisplatin for muscle-invasive upper tract urothelial carcinoma: A retrospective single-center cohort analysis. J Int Med Res Zhang J, Xiao Y, Cai D, Zhu H, Zhong W. PMID: 41912237 [PubMed - indexed for MEDLINE]
	Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment. J Natl Compr Canc Netw Su ZT, Florissi IS, Geller AE, Johnson Iii BA, Hoffman-Censits JH, Patel SH, Townsend JP, Hahn NM, Kates MR. PMID: 41911914 [PubMed - as supplied by publisher]
	EPR26-181: Racial and Ethnic Demographic Reporting in Studies Cited by the NCCN Testicular Cancer Guidelines: An Evidence Audit. J Natl Compr Canc Netw Sapkota S, Vemula SSM, Shah N, Motkur S, Bowen A, Sanka S, Kaur R, Bommanaveni A, Alshaikhli A, Isaac D. PMID: 41911765 [PubMed - in process]
	CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis. J Natl Compr Canc Netw Zhou S, Desai D, Benjamin S, Tsao CK. PMID: 41911734 [PubMed - in process]
	HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Vemula SSM, Kamal F, Fernet L, Afridi S, Shah N, Faheem MSB, Gergis S, Isaac D. PMID: 41911710 [PubMed - in process]
	Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. JCO Precis Oncol Moussa MJ, Andreev-Drakhlin AY, Venkatesan AM, Matin SF, Xiao L, Tidwell RSS, Shah AY, Adriazola AC, Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT. PMID: 41911516 [PubMed - indexed for MEDLINE]
	Development of Machine Learning Models for Predicting Prostate Cancer in Biopsy Candidates Using Prostate-Specific Antigen, Magnetic Resonance Imaging, and Hematologic Parameters. Prostate Özlü DN, Ar, Emir B, Ayten A, Sungur U, Ek, Polat H, Karada, Bitkin A. PMID: 41911495 [PubMed - as supplied by publisher]
	Concurrent AI-human interaction in prostate cancer MRI interpretation: More hype than help? Eur Radiol Exp Ponsiglione A, Di Costanzo G, Ponsiglione AM, Riccio C, Rinaldo A, Tucci AG, Pinto L, Palumbo L, Angelone F, Amato F, Stanzione A, Cuocolo R, Girometti R, Padhani AR, Imbriaco M. PMID: 41910833 [PubMed - indexed for MEDLINE]
	Perioperative and oncological outcomes of thulium laser-ERBT versus conventional TURBT in non-muscle invasive bladder cancer: a meta-analysis of 2,934 patients. Lasers Med Sci Chen D, Zhou Z, Wei G, Zhang F. PMID: 41910817 [PubMed - in process]
	Uncommon but aggressive: A case series on urinary bladder neuroendocrine carcinomas. J Cancer Res Ther Jha T, Ahuja A, Sharma M, Goel HK. PMID: 41910308 [PubMed - indexed for MEDLINE]
	Renal cell carcinoma with hemangioblastoma-like features: A rare entity and a dignostic challenge. J Cancer Res Ther Derqaoui S, Mesmoudi S, Znati K, Bernoussi Z. PMID: 41910306 [PubMed - indexed for MEDLINE]
	AR-V7 expression in primary non-metastatic prostate cancer and its role in disease progression following initial therapy: a systematic review and meta-analysis. Prostate Int Quintanilha M, Saugo Faria H, Leal de Oliveira H, Meira Martins L, Simoni Brum I. PMID: 41908243 [PubMed]
	Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions. Prostate Int Roldan-Testillano R, Rodriguez-Sanchez L, Covarrubias C, Durazo-Ruiz F, Arezki A, Anidjar M, Sanchez-Salas R. PMID: 41908235 [PubMed]
	External validation of the cancer of the prostate risk assessment score to predict treatment failure after high-intensity focused ultrasound. Prostate Int Brazão ÉS Jr, Santos VE, Mourão TC, Gomes DC, Nobre JQC, Brazão GP, de Oliveira RAR, da Silva C, da Costa WH, Guimarães GC, Zequi SC. PMID: 41908230 [PubMed]
	Familial Risks in 317Â 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics. Eur Urol Open Sci Hemminki K, Zitricky F, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki O. PMID: 41908211 [PubMed]
	Novel Strategies for Precision Diagnosis and Treatment of Prostate Cancer Based on Multifunctional Nanocarrier Systems. Int J Nanomedicine Tang Z, Shen S, Gu C, Li S, Ni J, Yang D, Mi Y. PMID: 41907374 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of (18)F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study. Front Med (Lausanne) Urso L, Feletti F, Lancia F, Canella F, Cittanti C, Badrane I, Adamantiadis S, Uccelli L, Iudicello A, Nieri A, Caracciolo M, Rambaldi I, Bisi R, Manco L, Bagni I, Guidoboni M, Calabrò L, Ippolito C, Giganti M, Bartolomei M. PMID: 41907293 [PubMed]
	Decision-Making Dilemmas Among Elderly Prostate Cancer Patients Receiving (177)Lu-PSMA Therapy: A Qualitative Study. Patient Prefer Adherence Chen Y, Liu C, Li R, He Y, Li L. PMID: 41907155 [PubMed]
	Sequential Intravesical Gemcitabine and Docetaxel for Non-Muscle Invasive Bladder Cancer: A Narrative Review Across Risk Groups. Res Rep Urol Hemmati Ghavshough M, Fu MZ, Islam R, Patel D, Ghodoussipour S, Packiam VT. PMID: 41907065 [PubMed]

Artikel 1 - 20 / 177148

Seite 1 von 8858

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung